S-312D

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameS-312D
Drug Alias NameS-312D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionMyocardial IschemiaTrauma, Nervous System +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShionogi & Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionMyocardial IschemiaTrauma, Nervous System +[4

Other Information

ATC CodeN/A
Related LinksN/A